عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

Wadi Al-Disah, a Captivating Illustration of Saudi Arabian Nature

A view of Wadi al-Disah in Saudi Arabia. (SPA)
A view of Wadi al-Disah in Saudi Arabia. (SPA)
TT
TT

Wadi Al-Disah, a Captivating Illustration of Saudi Arabian Nature

A view of Wadi al-Disah in Saudi Arabia. (SPA)
A view of Wadi al-Disah in Saudi Arabia. (SPA)

Winter has its splendor in Saudi Arabia, especially in the north, and even in parts of the country that are characterized by moderate weather in the summer, like the south. Many tourists and visitors flock to the country at this time of every year.

This year is no different as the Kingdom succeeded in curbing the spread of the Covid-19 pandemic.

“Winter is around you” is a Saudi marketing slogan that highlights the importance of this season for the tourism sector in Saudi Arabia. Winter becomes more than just a season when one can enjoy a road trip in the desert, mountains, coasts and valleys.

Wadi Al-Disah, one of the most visited locations in Saudi Arabia this year, is a valley that is located in the heart of the Prince Mohammed bin Salman Nature Reserve and extends into the city of Neom. Wadi Al-Disah boasts some of the most beautiful natural landscapes in the Kingdom, with its crystal-clear streams, flowing springs, lush patches of green and towering palm trees. The valley’s Nabataean facade and rock-carved tombs only add to its beauty.

Asharq Al-Awsat met several tourists who came to enjoy Saudi Arabia’s natural beauty from across the globe. Through the lens of their cameras, they documented what they saw and posted the pictures on their social media.

Nataliya, a photographer from Ukraine, said that it was the first time that she visited the valley and that she and her husband couldn’t be more impressed with what they had seen. She added: “This valley is definitely the most beautiful place we have visited in our trip.”

A Brazilian tourist said that she decided to visit Wadi Al-Disah after she saw photos of the valley on Instagram. “I loved it ... Wadi Al-Disah is one of the most beautiful places I have ever seen,” she said, adding that she was captivated by its mesmerizing nature and unique landscapes.

Saudi photographer Younis Al-Dohaiman also said that he first discovered the valley while scrolling through Instagram photos of travelers who had visited it during winter.

Tourists can visit Wadi Al-Disah in winter or summer. Temperatures in the area range from 12 degrees Celsius in winter to 31 degrees during the summer, while it rains for eight months a year on average.

The Saudi Public Investment Fund intends to invest in new development projects in Wadi Al-Disah that aim to preserve the environment and wildlife of the valley, while hoping to transform it into a major touristic attraction.

Most Viewed

 
 
Varieties

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”